|
|
Post by kc on Jun 14, 2015 22:02:29 GMT -5
Liane, as administrator can you just block him. He showed his true stripes . No away with him. OK, I think it's time to get back to the original topic of this thread, and not focus on other annoyances. Thank You! |
|
|
|
Post by oscarlonzo on Jun 14, 2015 23:26:02 GMT -5
Fascinating! Someone posts about the new trial and simply ask why it is being done since it seemed redundant and obviously not required by the FDA. I offered one suggestion that perhaps it was to clarify dosing issues that had arisen since afrezza's introduction -- for example: dosing problems
Seems like a reasonable suggestion but, for some reason that provokes a half dozen attacks! In any case, I then ask a simple enough question -- why didn't SNY and/or MNKD ever mention the trial? Given that the latest headlines consisted of: "MannKind Corporation Sinks: CFO Says 'We're Not There Yet' With Afrezza Benzinga(Wed, Jun 10) 5 Stocks a Raging Rally Could Not Save at 24/7 Wall St.(Wed, Jun 10) The 6 Most Shorted Nasdaq Stocks in May at 24/7 Wall St.(Wed, Jun 10) Why MannKind Could Be an Endless Tug-of-War Stock at 24/7 Wall St.(Tue, Jun 9) Diabetes Docs Wary of MannKind's Afrezza Insulin, Analyst Survey Finds at TheStreet(Tue, Jun 9)" ...one would think that MNKD would be eager to issue a PR with some good news for a change. The response? Yet more attacks! The question seems perfectly reasonable to me! Did they even know about the trial? |
|
|
|
Post by jefferson on Jun 14, 2015 23:53:18 GMT -5
I'm not sure I understand why everyone is jumping Oscar either? His questions/concerns don't seem to justify the response? I'm a fan of the board. Let's let all reasonable voices be heard.
J
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 15, 2015 0:13:45 GMT -5
Fascinating! Someone posts about the new trial and simply ask why it is being done since it seemed redundant and obviously not required by the FDA. I offered one suggestion that perhaps it was to clarify dosing issues that had arisen since afrezza's introduction -- for example: dosing problems
Seems like a reasonable suggestion but, for some reason that provokes a half dozen attacks! In any case, I then ask a simple enough question -- why didn't SNY and/or MNKD ever mention the trial? Given that the latest headlines consisted of: "MannKind Corporation Sinks: CFO Says 'We're Not There Yet' With Afrezza Benzinga(Wed, Jun 10) 5 Stocks a Raging Rally Could Not Save at 24/7 Wall St.(Wed, Jun 10) The 6 Most Shorted Nasdaq Stocks in May at 24/7 Wall St.(Wed, Jun 10) Why MannKind Could Be an Endless Tug-of-War Stock at 24/7 Wall St.(Tue, Jun 9) Diabetes Docs Wary of MannKind's Afrezza Insulin, Analyst Survey Finds at TheStreet(Tue, Jun 9)" ...one would think that MNKD would be eager to issue a PR with some good news for a change. The response? Yet more attacks! The question seems perfectly reasonable to me! Did they even know about the trial? Bash bash and more bashing. Yet, weekly RX numbers grow. All of this w/o advertising. Bash bash and more bashing. Current Afrezza users are "in heaven", an a1c smaller than previously thought possible. Bash bash and more bashing. If the rumor is true, SNY is gonna make Afrezza a star. So please continue your tirade. Attack everyone. Why you are here is obvious. Why you have not been booted, god knowns. But watch out. MNKD has short fuse, any catalyst and your a$$ will be hurting big. |
|
|
|
Post by papihoyos on Jun 15, 2015 9:53:46 GMT -5
Let him speak out, we live in a nation of free speak. As long as he's respectful, we should let him speak.
|
|
|
|
Post by notamnkdmillionaire on Jun 15, 2015 9:57:39 GMT -5
Let him speak out, we live in a nation of free speak. As long as he's respectful, we should let him speak. As long as a person sticks to the TOU agreement, all is good. But there is no such thing as free speech on private message boards. Free speech pertains to the government not being able to silence us. But a message board surely can censor if it wishes. |
|
|
|
Post by papihoyos on Jun 15, 2015 10:15:33 GMT -5
This a public board, not private. Anyone can join. The TOU doesn't require us not to be critical of MNKD. I want an open respectfully forum otherwise I don't need to be here. we are not fachist
|
|
|
|
Post by BD on Jun 15, 2015 10:24:02 GMT -5
Folks, the key here is to address the facts/topic and not to be attacking the poster. I've seen this time and time again over the years: someone's opinion goes against the grain of the majority of members of a board, and a lynch mob mentality ensues. Typically this occurs when the board is mostly biased long (as we are here) and the poster exhibits a short bias. This is not against the rules of the board, nor is it even necessarily a bad thing. It is very, very difficult to gauge a member's intentions. The best thing to do all-around is, IMO, to give members the benefit of the doubt (that they honestly hold the opinions they are posting) and try to assist them to see things from the point of view you regard as being reality--without accusing them of dissembling.
I have actually been part of the vast long majority on a board that ended up having the wrong view of reality, while the "basher" shorts ended up being right. Going through that, I have evolved a grudging respect for those who are willing to put their opinions out amidst a hostile mob. I hate to see anyone who may simply be putting out their honest--even if probably misguided--opinions get personally trashed.
If we have truly strong convictions regarding the viability of our MNKD positions, we don't need to personally trash the nay-sayers, whether they're bashers or simply uneducated. Please remember that.
|
|
|
|
Post by notamnkdmillionaire on Jun 15, 2015 10:34:06 GMT -5
This a public board, not private. Anyone can join. The TOU doesn't require us not to be critical of MNKD. I want an open respectfully forum otherwise I don't need to be here. we are not fachist You missed my point completely. But no worries. |
|
|
|
Post by oscarlonzo on Jun 15, 2015 10:59:41 GMT -5
As of almost noon today, Monday the 15th, I see no press release from either MNKD or SNY about the trial. Why? If it is for an EU application, then it is highly significant news and needs to be broadcast. Would anyone disagree with that? Regardless, MNKD and/or SNY should clarify what the deal is, otherwise its purpose becomes "short" food.
|
|
|
|
Post by jimbering on Jun 15, 2015 11:13:44 GMT -5
I'm not sure I understand why everyone is jumping Oscar either? His questions/concerns don't seem to justify the response? I'm a fan of the board. Let's let all reasonable voices be heard. J I think people are upset because at least some of know that oscarlonzo is OPC11 who I believe has been banned on this board. On the YMB he posts as OPC11 and is very obnoxious. Here and on TuDiabetes he uses the oscar name and attempts to be more polite which is difficult for him. On Seeking Alpha he uses the name BearCrusher. All the same guy. He invested too heavily in MNKD and chased, a mistake. He lost a lot of money and now hates MNKD management blaming them for his poor judgment. He spreads FUD wherever he can. Especially egregious is his spreading FUD about Afrezza on diabetic boards. This is a very bitter, hateful man. |
|
|
|
Post by liane on Jun 15, 2015 11:14:18 GMT -5
It simply is not significant until there are results. Most drug companies do not make a big to-do about small studies like this.
|
|
|
|
Post by kimi on Jun 15, 2015 11:21:03 GMT -5
PR will disclosed usually in case of first patient enrollement - you should now that!
Or do you think Sanofi wants to show through the backdoor (not informing ROW), Afrezza is non superior to Humalog?
Is that your Agenda?
|
|
|
|
Post by dreamboatcruise on Jun 15, 2015 11:22:41 GMT -5
As of almost noon today, Monday the 15th, I see no press release from either MNKD or SNY about the trial. Why? If it is for an EU application, then it is highly significant news and needs to be broadcast. Would anyone disagree with that? Regardless, MNKD and/or SNY should clarify what the deal is, otherwise its purpose becomes "short" food. I think you are viewing things through the lens of a MNKD shareholder. I hope, actually I am confident, that the agreement put in place with Sanofi is structured to align the long term interests of MNKD and Sanofi in making Afrezza a hugely successful product. However, it is amply apparent that there is not an alignment between Sanofi's short term interests and those of MNKD investors looking for a near term share price increase. Sanofi is not at the point of trying to sell Afrezza to the financial community as something that will materially affect their bottom line. Other than a share price incentive, which it appears Sanofi has no interest in, what is the "need" that they would have to broadcast anything? They are the only ones whose disagreement with you would really matter. Not meaning to be too critical here, but everyone has to realize that MNKD and SNY, because they can't or don't have a reason to, are not going to do things aimed at supporting MNKD share price or hindering the efforts of shorts. You need to at least be tolerant of the volatility, or be willing to take advantage of it, if you want to play in MNKD shares. If you're long MNKD wishing for the food to be taken away from shorts by a proactive stance from either company with regard to information flow... you probably should not be invested because you're not basing your investment on reality. |
|
|
|
Post by oscarlonzo on Jun 15, 2015 14:05:05 GMT -5
"It simply is not significant until there are results.
"
So you're saying that if this trial is being done in preparation for a European application, then that information is "not significant"? I call for a vote. Who all agrees that if the trial is being done in preparation for a EU application, then MNKD and SNY shouldn't tell anyone until after the results are in?
|
|
OK, I think it's time to get back to the original topic of this thread, and not focus on other annoyances. Thank You!
